VACCINES AND COMPOSITIONS BASED ON SARS-COV-2 S PROTEIN
This disclosure provides vaccines and compositions based on SARS-CoV-2 S protein, and specifically relates to recombinant SARS-CoV-2 spike protein (Sprotein) and mRNA and DNA coding thereof. This disclosure also relates to recombinant plasmid comprising DNA sequence encoding recombinant S protein. T...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WEN, Jian MA, Lin ZHANG, Hong ZHONG, Huiling ZHANG, Bill Biliang |
| description | This disclosure provides vaccines and compositions based on SARS-CoV-2 S protein, and specifically relates to recombinant SARS-CoV-2 spike protein (Sprotein) and mRNA and DNA coding thereof. This disclosure also relates to recombinant plasmid comprising DNA sequence encoding recombinant S protein. This disclosure further relates to composition comprising the recombinant S protein and/or mRNA mentioned above, mRNA-carrier particle such as lipid nanoparticle (LNP), and composition such as a vaccine composition.
La présente divulgation concerne des vaccins et des compositions basés sur la protéine S du SARS-CoV-2, et concerne spécifiquement la protéine de spicule du SARS-CoV-2 recombinante (protéine S) et l'ARNm et le codage de l'ADN de celle-ci. La présente divulgation concerne également un plasmide recombinant comprenant une séquence d'ADN codant pour la protéine S recombinante. La présente divulgation concerne en outre une composition comprenant la protéine S recombinante et/ou l'ARNm mentionné ci-dessus, une particule porteuse d'ARNm telle qu'une nanoparticule lipidique (LNP), et une composition telle qu'une composition de vaccin. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023130637A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023130637A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023130637A13</originalsourceid><addsrcrecordid>eNrjZDAPc3R29vRzDVZw9HNRcPb3DfAP9gzx9PcLVnByDHZ1UfD3Uwh2DArWdfYP0zVSCFYICPIPcfX042FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGxobGBmbG5o6GxsSpAgC6PijH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>VACCINES AND COMPOSITIONS BASED ON SARS-COV-2 S PROTEIN</title><source>esp@cenet</source><creator>WEN, Jian ; MA, Lin ; ZHANG, Hong ; ZHONG, Huiling ; ZHANG, Bill Biliang</creator><creatorcontrib>WEN, Jian ; MA, Lin ; ZHANG, Hong ; ZHONG, Huiling ; ZHANG, Bill Biliang</creatorcontrib><description>This disclosure provides vaccines and compositions based on SARS-CoV-2 S protein, and specifically relates to recombinant SARS-CoV-2 spike protein (Sprotein) and mRNA and DNA coding thereof. This disclosure also relates to recombinant plasmid comprising DNA sequence encoding recombinant S protein. This disclosure further relates to composition comprising the recombinant S protein and/or mRNA mentioned above, mRNA-carrier particle such as lipid nanoparticle (LNP), and composition such as a vaccine composition.
La présente divulgation concerne des vaccins et des compositions basés sur la protéine S du SARS-CoV-2, et concerne spécifiquement la protéine de spicule du SARS-CoV-2 recombinante (protéine S) et l'ARNm et le codage de l'ADN de celle-ci. La présente divulgation concerne également un plasmide recombinant comprenant une séquence d'ADN codant pour la protéine S recombinante. La présente divulgation concerne en outre une composition comprenant la protéine S recombinante et/ou l'ARNm mentionné ci-dessus, une particule porteuse d'ARNm telle qu'une nanoparticule lipidique (LNP), et une composition telle qu'une composition de vaccin.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230713&DB=EPODOC&CC=WO&NR=2023130637A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230713&DB=EPODOC&CC=WO&NR=2023130637A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WEN, Jian</creatorcontrib><creatorcontrib>MA, Lin</creatorcontrib><creatorcontrib>ZHANG, Hong</creatorcontrib><creatorcontrib>ZHONG, Huiling</creatorcontrib><creatorcontrib>ZHANG, Bill Biliang</creatorcontrib><title>VACCINES AND COMPOSITIONS BASED ON SARS-COV-2 S PROTEIN</title><description>This disclosure provides vaccines and compositions based on SARS-CoV-2 S protein, and specifically relates to recombinant SARS-CoV-2 spike protein (Sprotein) and mRNA and DNA coding thereof. This disclosure also relates to recombinant plasmid comprising DNA sequence encoding recombinant S protein. This disclosure further relates to composition comprising the recombinant S protein and/or mRNA mentioned above, mRNA-carrier particle such as lipid nanoparticle (LNP), and composition such as a vaccine composition.
La présente divulgation concerne des vaccins et des compositions basés sur la protéine S du SARS-CoV-2, et concerne spécifiquement la protéine de spicule du SARS-CoV-2 recombinante (protéine S) et l'ARNm et le codage de l'ADN de celle-ci. La présente divulgation concerne également un plasmide recombinant comprenant une séquence d'ADN codant pour la protéine S recombinante. La présente divulgation concerne en outre une composition comprenant la protéine S recombinante et/ou l'ARNm mentionné ci-dessus, une particule porteuse d'ARNm telle qu'une nanoparticule lipidique (LNP), et une composition telle qu'une composition de vaccin.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAPc3R29vRzDVZw9HNRcPb3DfAP9gzx9PcLVnByDHZ1UfD3Uwh2DArWdfYP0zVSCFYICPIPcfX042FgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgZGxobGBmbG5o6GxsSpAgC6PijH</recordid><startdate>20230713</startdate><enddate>20230713</enddate><creator>WEN, Jian</creator><creator>MA, Lin</creator><creator>ZHANG, Hong</creator><creator>ZHONG, Huiling</creator><creator>ZHANG, Bill Biliang</creator><scope>EVB</scope></search><sort><creationdate>20230713</creationdate><title>VACCINES AND COMPOSITIONS BASED ON SARS-COV-2 S PROTEIN</title><author>WEN, Jian ; MA, Lin ; ZHANG, Hong ; ZHONG, Huiling ; ZHANG, Bill Biliang</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023130637A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WEN, Jian</creatorcontrib><creatorcontrib>MA, Lin</creatorcontrib><creatorcontrib>ZHANG, Hong</creatorcontrib><creatorcontrib>ZHONG, Huiling</creatorcontrib><creatorcontrib>ZHANG, Bill Biliang</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WEN, Jian</au><au>MA, Lin</au><au>ZHANG, Hong</au><au>ZHONG, Huiling</au><au>ZHANG, Bill Biliang</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>VACCINES AND COMPOSITIONS BASED ON SARS-COV-2 S PROTEIN</title><date>2023-07-13</date><risdate>2023</risdate><abstract>This disclosure provides vaccines and compositions based on SARS-CoV-2 S protein, and specifically relates to recombinant SARS-CoV-2 spike protein (Sprotein) and mRNA and DNA coding thereof. This disclosure also relates to recombinant plasmid comprising DNA sequence encoding recombinant S protein. This disclosure further relates to composition comprising the recombinant S protein and/or mRNA mentioned above, mRNA-carrier particle such as lipid nanoparticle (LNP), and composition such as a vaccine composition.
La présente divulgation concerne des vaccins et des compositions basés sur la protéine S du SARS-CoV-2, et concerne spécifiquement la protéine de spicule du SARS-CoV-2 recombinante (protéine S) et l'ARNm et le codage de l'ADN de celle-ci. La présente divulgation concerne également un plasmide recombinant comprenant une séquence d'ADN codant pour la protéine S recombinante. La présente divulgation concerne en outre une composition comprenant la protéine S recombinante et/ou l'ARNm mentionné ci-dessus, une particule porteuse d'ARNm telle qu'une nanoparticule lipidique (LNP), et une composition telle qu'une composition de vaccin.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2023130637A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | VACCINES AND COMPOSITIONS BASED ON SARS-COV-2 S PROTEIN |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T00%3A32%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WEN,%20Jian&rft.date=2023-07-13&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023130637A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |